Earnings Outlook For Quest Diagnostics
Portfolio Pulse from Benzinga Insights
Quest Diagnostics (NYSE:DGX) is expected to release its quarterly earnings report on Thursday, 2024-02-01, with analysts predicting an EPS of $2.11. Investors are looking for an earnings beat and positive guidance for future growth. In the past, DGX's stock price has been sensitive to earnings performance and guidance rather than just meeting or beating estimates. Last quarter, DGX beat the EPS estimate by $0.03, leading to a 1.53% stock price increase the following day. However, over the last year, the stock has declined by 11.21%, indicating potential investor dissatisfaction. The upcoming earnings report could influence the stock's short-term performance.
January 31, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Quest Diagnostics is anticipated to report quarterly earnings with an expected EPS of $2.11. Positive guidance could boost the stock, while a year-long decline of 11.21% may pressure the company to deliver strong results.
Given the historical sensitivity of DGX's stock price to earnings performance and guidance, a positive report and forecast could lead to an uptick in the stock price, especially if the company beats the EPS estimate and provides strong future guidance. However, the recent negative trend in stock performance indicates a cautious optimism, as investors may be looking for significant positive news to counteract the past year's decline.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100